Delisting risk
Scinai Immunotherapeutics (ADR) (SCNI)
Runs an Israeli CDMO alongside antibody programs for inflammation and immunology.
$2.04
Pre-market−0.31 (−13.19%)
At close$2.35(−4.47%)
Something off on this page? Send us feedback.
Next report
Dec 2, 2026
in 90 days
EPS estimate
−$8.50
Revenue estimate
$494.6K
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Nov '24May '25May '25Sep '25Dec '25Jun '26Aug '26Dec '26
Reported$8.40−$10.40$0.00−$3.57−$1.33$0.94−$0.74Pending
Estimate———————−$8.50
Surprise————————
RevenueReportedEstimate
Nov '24May '25May '25Sep '25Dec '25Jun '26Aug '26Dec '26
Reported$44.2K$56.5K$158.0K$115.5K$277.3K$487.7K$467.9KPending
Estimate———————$494.6K
Surprise————————
History
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2026 | −$8.50 | — | — |
| Aug 2026 | — | −$0.74 | — |
| Jul 2026 | — | — | — |
| Jul 2026 | — | — | — |
| Jun 2026 | — | $0.94 | — |
| May 2026 | — | — | — |
| Dec 2025 | — | −$1.33 | — |
| Sep 2025 | — | −$3.57 | — |
The latest year is open to everyone — the 38 quarters behind it read with an account. Sign in | |||
| May 2025 | |||
| May 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| Jul 2024 | |||
| May 2024 | |||
| Oct 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Apr 2023 | |||
| Sep 2022 | |||
| Jun 2022 | |||
| Mar 2022 | |||
| Dec 2021 | |||
| Sep 2021 | |||
| Jun 2021 | |||
| Mar 2021 | |||
| Dec 2020 | |||
| Sep 2020 | |||
| Jun 2020 | |||
| Mar 2020 | |||
| Dec 2019 | |||
| Sep 2019 | |||
| Jun 2019 | |||
| Mar 2019 | |||
| Dec 2018 | |||
| Sep 2018 | |||
| Jun 2018 | |||
| Mar 2018 | |||
| Dec 2017 | |||
| Sep 2017 | |||
| Jun 2017 | |||
| Mar 2017 | |||
| Dec 2016 | |||
| Sep 2016 | |||
| Jun 2016 | |||
| Mar 2016 | |||
| Dec 2015 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2, 2026 | −$8.50 | — | — | $494.6K | — | — | — |
| Aug 24, 2026 | — | −$0.74 | — | — | $467.9K | — | −2.8% |
| Jul 7, 2026 | — | — | — | — | — | — | — |
| Jul 1, 2026 | — | — | — | — | — | — | — |
| Jun 10, 2026 | — | $0.94 | — | — | $487.7K | — | −0.6% |
| May 7, 2026 | — | — | — | — | — | — | — |
| Dec 2, 2025 | — | −$1.33 | — | — | $277.3K | — | +11.7% |
| Sep 2, 2025 | — | −$3.57 | — | — | $115.5K | — | +4.6% |
The latest year is open to everyone — the 38 quarters behind it read with an account. Sign in | |||||||
| May 30, 2025 | |||||||
| May 7, 2025 | |||||||
| Nov 22, 2024 | |||||||
| Aug 15, 2024 | |||||||
| Jul 2, 2024 | |||||||
| May 15, 2024 | |||||||
| Oct 31, 2023 | |||||||
| Aug 11, 2023 | |||||||
| May 15, 2023 | |||||||
| Apr 17, 2023 | |||||||
| Sep 30, 2022 | |||||||
| Jun 30, 2022 | |||||||
| Mar 31, 2022 | |||||||
| Dec 31, 2021 | |||||||
| Sep 30, 2021 | |||||||
| Jun 30, 2021 | |||||||
| Mar 31, 2021 | |||||||
| Dec 31, 2020 | |||||||
| Sep 30, 2020 | |||||||
| Jun 30, 2020 | |||||||
| Mar 31, 2020 | |||||||
| Dec 31, 2019 | |||||||
| Sep 30, 2019 | |||||||
| Jun 30, 2019 | |||||||
| Mar 31, 2019 | |||||||
| Dec 31, 2018 | |||||||
| Sep 30, 2018 | |||||||
| Jun 30, 2018 | |||||||
| Mar 31, 2018 | |||||||
| Dec 31, 2017 | |||||||
| Sep 30, 2017 | |||||||
| Jun 30, 2017 | |||||||
| Mar 31, 2017 | |||||||
| Dec 31, 2016 | |||||||
| Sep 30, 2016 | |||||||
| Jun 30, 2016 | |||||||
| Mar 31, 2016 | |||||||
| Dec 31, 2015 | |||||||